See the DrugPatentWatch profile for Vyvanse
The price of Vyvanse (lisdexamfetamine dimesylate) can vary significantly depending on factors such as dosage, quantity purchased, and whether a prescription is filled at a retail pharmacy or obtained through a discount program. Without insurance, a prescription for a 30-day supply of Vyvanse can range from approximately $250 to over $350 [1].
How much does Vyvanse cost with insurance?
Insurance coverage for Vyvanse can substantially reduce out-of-pocket costs. However, the exact copay amount is determined by the specific insurance plan. Some plans may require a prior authorization, and a tiered formulary could also affect the cost. Patients often find that their copay might range from $10 to $75 per month, depending on their insurance benefits [1].
Are there discount cards or coupons for Vyvanse?
Yes, several discount programs can lower the cost of Vyvanse. Takeda, the manufacturer of Vyvanse, offers a savings card program for commercially insured patients. This program can reduce the monthly cost to as little as $30 for eligible individuals [1]. For those who are uninsured or whose insurance does not cover Vyvanse, discount cards can also be accessed through various online pharmacy discount platforms.
When does the Vyvanse patent expire?
The primary patents for Vyvanse have begun to expire, opening the door for generic versions. For instance, some key patents were set to expire around August 2023 [2]. The availability of generic lisdexamfetamine dimesylate is expected to impact pricing.
What are the generic alternatives to Vyvanse?
Following patent expirations, generic versions of lisdexamfetamine dimesylate are becoming available. These generics are bioequivalent to the brand-name Vyvanse and are expected to offer a more affordable treatment option for ADHD [2].
What is the typical dosage of Vyvanse?
Vyvanse is available in various strengths, typically ranging from 10 mg to 70 mg. The dosage is individualized based on a patient's needs and response to treatment. The cost of the medication is often tied to the specific dosage prescribed [1].
Where can I find the latest information on Vyvanse patent expirations?
DrugPatentWatch.com provides detailed and up-to-date information on drug patents and their expiration dates. This resource can be valuable for tracking the patent landscape of medications like Vyvanse and understanding when generic alternatives are likely to become available [2].
What is the history of Vyvanse patents?
Vyvanse has been protected by several patents since its approval. These patents cover various aspects of the drug, including its formulation and method of use. As these patents expire, generic manufacturers can seek approval to market their versions of the drug [2].
How does Vyvanse work to treat ADHD?
Vyvanse is a central nervous system stimulant. It works by increasing the levels of certain neurotransmitters in the brain, such as dopamine and norepinephrine, which are believed to play a role in attention and impulse control. Lisdexamfetamine is a prodrug that is converted to dextroamphetamine in the body [3].
What are the side effects of Vyvanse?
Common side effects of Vyvanse can include decreased appetite, dry mouth, insomnia, weight loss, and anxiety. More serious side effects, though less common, may include cardiovascular issues, psychiatric problems, and circulation problems in the fingers and toes [3].
Sources:
[1] https://www.singlecare.com/drugs/vyvanse
[2] https://drugpatentwatch.com/us/lisdexamfetamine-dimesylate/vyvanse
[3] https://www.webmd.com/drugs/2/drug-160071/vyvanse-oral/details